Stelosi 5 Dosage & Drug Information

Concise Prescribing Info Bahasa Concise Prescribing Info

Concise Prescribing Info

Contents

Trifluoperazine HCl

Indications/Uses

Low dose: Control of nervousness, tension, agitation. Nausea & vomiting from various origins. High dose: Acute & chronic catatonic, hebephrenic schizophrenia & paranoia, psychosis due to organic brain damage & intoxication. Control of manic-depressive disease symptoms.

Dosage/Direction for Use

Adult Outpatient 1-2 mg twice daily. Max: 6 mg daily, hospitalized patient 2-5 mg twice daily, may be increased in increments of 5 mg w/in 3 days.

Administration

Should be taken with food.

Contraindications

Coma, severe depression, blood dyscrasia, bone-marrow depression, hepatic disease.

Adverse Reactions

Asthenia, nervousness, drowsiness, insomnia, dry mouth, blurred vision, muscle weakness, hypotension, extrapyramidal symptoms (high-dose usage or patients >40 yr).

View ADR Reporting Link

MIMS Class

Antipsychotics

ATC Classification

N05AB06 - trifluoperazine ; Belongs to the class of phenothiazine antipsychotics with piperazine structure.

Regulatory Classification

Presentation/Packing

Form

Stelosi 5 FC tab 5 mg

Packing/Price

10 × 10's (Rp57,750/boks)

Stelosi 5

trifluoperazine

Manufacturer:

Mersifarma TM